Muscle physiology TikTok meets peptide hype: what holds up?

What did @justadoctorwannabe actually say?

The creator gave a textbook walkthrough of how paired muscles work during movement. Their core claim: muscles come in opposing pairs, where one "contracts to generate the main force" (the agonist, or prime mover) while the other performs the opposite action (the antagonist). They used elbow flexion and extension as the main example, naming the biceps brachii and triceps brachii specifically, and then listed several other paired actions: flexion/extension, elevation/depression, and pronation/supination.

No peptides, no supplements, no dosing claims. Just anatomy. The video stays in its lane, which is worth noting before we pick it apart.

Does the science back this up?

Yes, broadly. The agonist-antagonist framework is one of the most well-established concepts in musculoskeletal physiology, and the creator got the fundamentals right. Where it gets more complicated is in the details, and those details matter if you are training, recovering from injury, or trying to understand how peptide therapies like BPC-157 interact with muscle tissue repair.

The foundational model here traces back to reciprocal inhibition described by Sherrington (1906, Journal of Physiology), where the agonist muscle's motor neurons inhibit the antagonist through spinal interneurons. This is not controversial. What the creator describes is consistent with how anatomy textbooks and peer-reviewed physiology literature characterize these roles. Moore, Dalley, and Agur's clinical anatomy reference and Hall's "Basic Biomechanics" (2019, McGraw-Hill) both describe prime movers and antagonists in essentially the same framework the creator uses.

What did they get wrong (or right)?

Mostly right, but there are real gaps. The biggest omission is the role of synergist muscles and stabilizers. Real movement is not a clean two-muscle story. When you flex your elbow, the brachialis and brachioradialis are also contracting alongside the biceps brachii. Ignoring synergists is a common oversimplification in anatomy content, and it can mislead people about injury risk and rehabilitation.

The creator also implies that when one muscle is the agonist, the antagonist is simply "relaxed." That is not always accurate. Co-contraction of agonist and antagonist pairs occurs during high-load, high-velocity, or unstable movement, a point documented extensively in electromyography (EMG) research. Cholewicki and McGill (1996, Journal of Biomechanics) demonstrated co-contraction in lumbar stabilization, and similar findings appear in limb studies. Calling the biceps simply "relaxed" during triceps-driven extension understates how the nervous system actually manages joint stability.

That said, for an entry-level anatomy explainer, the core claim about agonist-antagonist pairs is accurate. Credit where it is due.

What should you actually know?

If you are here because you found this video while researching peptide therapy or recovery protocols, here is the practical bridge. Agonist-antagonist balance is directly relevant to how injuries develop and how peptides like BPC-157 are studied in the context of tendon and muscle repair. Tendon injuries often involve imbalances between opposing muscle groups, specifically weakness or delayed activation in antagonists.

BPC-157, a pentadecapeptide studied in animal models, has shown effects on tendon fibroblast proliferation and growth factor expression in studies like Pevec et al. (2010, Journal of Orthopaedic Research). Understanding which muscles and tendons are agonists versus antagonists in a given movement is foundational for discussing where soft tissue repair might theoretically apply. It is not a treatment claim. It is anatomy context.

The paired actions the creator lists (flexion/extension, elevation/depression, pronation/supination) are real and well-categorized. But movement is more layered than pairs. Fixator muscles hold joints stable. Synergists fine-tune force. If you are working with a clinician on a recovery plan, the oversimplified two-muscle model is a starting point, not the whole picture.